drugset / Trial / NCT01577706

Spectroscopic Imaging at 4T: A Drug Challenge Study

NCT01577706

Terminated 7 enrolled Mclean Hospital
RandomizedCrossoverDouble-blindBasic science

Summary

An advanced technique for rapid magnetic resonance proton spectroscopic imaging (1H-MRSI) will be employed in a drug challenge study in healthy volunteers to spatially map and measure acute changes in the brain chemicals GABA, glutamate and glutamine after administration of a drug. Three condition will be tested in a double-blind fashion, i)depressant, ii)stimulant, iii)placebo. It is hypothesized that unique and reproducible spatial and directional metabolic response patterns will be observed, unique to each condition within the brain.

Timeline

Start
2013-06
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alprazolam Small molecule 1 mg
Comparator Dextroamphetamine Small molecule 20 mg

Indications

No indication recorded.